Los Angeles, CA July 15th 2014 – Elizabeth Holmes graces the front page of today’s issue of the San Jose Mercury to offer a prospective outlook on her company, Theranos, and its role in shaping the future of healthcare. DeciBio and I are once again thrilled to be quoted for our thoughts on the disruptive Silicon Valley start-up.This new article, written by San Jose Mercury columnist Michelle Quinn, places the Jobsian Founder and CEO in the context of her Palo Alto predecessors to investigate the common bond between “young, bold and single-minded” industry phenoms. Whether Theranos will be able follow in the footsteps of visionary companies like Apple and Tesla in its pursuit of a "revolution" remains unclear. Nonetheless, DeciBio will continue to provide the most comprehensive market analysis on the bright young company and any future developments in the lab diagnostics industry.Check-back in September to read DeciBio’s full report on Theranos.Author: Eric Lakin, Analyst at DeciBio Consulting, LLClakin@decibio.comConnect with Eric Lakin on Google+https://plus.google.com/+EricLakin